View printer-friendly version << Back
MEDNAX Acquires Virginia Neonatal, Texas Pediatric Cardiology Practices

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Apr. 1, 2009-- MEDNAX, Inc., (NYSE: MD) today announced that it has completed two separate physician group practice acquisitions, a neonatal group practice based in the Hampton Roads region of Virginia, and a pediatric cardiology practice serving patients in El Paso, Texas.

The physicians joining as a result of both transactions will practice as part of MEDNAX’s Pediatrix Medical Group, a national medical group that encompasses the nation’s leading neonatal, maternal-fetal medicine and pediatric cardiology physician group practice.

Hampton Roads Neonatology, PLC, includes three physicians and six nurse practitioners who staff the Level III neonatal intensive care unit (NICU) and well-baby nursery at Riverside Regional Medical Center in Newport News, Virginia. Annual patient volume is approximately 7,000 NICU patient days and 8,000 newborn nursery patient days.

“Our practice has grown as we’ve supported an expanding labor and delivery program in our community,” said Adel Abdallah, M.D., who has been practicing at Riverside since 1994, and will serve as Pediatrix’s medical director at Riverside Regional. “We look forward to practicing as part of Pediatrix as a way to take our practice to the next level. Our physicians are excited about participating in clinical quality and research programs that are now available to us as part of Pediatrix.”

Physicians practicing as part of Pediatrix Medical Group contribute to the world’s largest neonatal outcomes database, which now has more than 10 million daily progress notes from more than half a million patients. The database is used to drive clinical research, continuing education and continuous quality improvement initiatives across the national group practice.

Separately, MEDNAX announced that it had completed the acquisition of Schuster Heart Center, P.A., a pediatric cardiology practice based in El Paso, Texas, effective February 27.

Jeffrey D. Schuster, M.D., is the founder and sole physician in the practice, which provides a range of cardiology services to pediatric patients, as well as fetal echocardiography services to patients throughout El Paso. Dr. Shuster has been providing patient care services in El Paso since 1990.

MEDNAX paid cash for the practices, which are expected to contribute immediately to the Company’s earnings. No additional terms of the transaction were disclosed.


MEDNAX, Inc., is a national medical group that comprises the nation’s leading provider of neonatal, maternal-fetal and pediatric physician subspecialty services as well as anesthesia services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was founded in 1979 and now includes neonatal physicians who provide services at more than 250 neonatal intensive care units, who collaborate with affiliated maternal-fetal medicine, pediatric cardiology and pediatric intensivist physician subspecialists to provide a clinical care continuum. Pediatrix is also the nation’s largest provider of newborn hearing screens. In 2007, the Company expanded into anesthesia services. Today, American Anesthesiology includes more than 450 anesthesiologists and advanced practitioners. MEDNAX, through its affiliated professional corporations, employs more than 1,250 physicians in 32 states and Puerto Rico. Additional information is available at

Certain statements and information in this press release may be deemed to contain forward-looking statements which may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”, “will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and similar expressions, and are based on assumptions and assessments made by MEDNAX’s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in MEDNAX’s most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s current reports on Form 8-K, filed with the Securities and Exchange Commission.

Source: MEDNAX, Inc.

Bob Kneeley, 954-384-0175, x-5300
Director, Investor Relations